Evidence map›Paper›PMID 36672213›Full record

ArticleCells2023

Fabrication Scaffold with High Dimensional Control for Spheroids with Undifferentiated iPS Cell Properties.

Hidetaka Togo, Kento Terada, Akira Ujitsugu, Yudai Hirose, Hiroki Takeuchi, Masanobu Kusunoki

Abstract read
In one paragraph

Article in Cells, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Hidetaka TogoGraduate School of Biology-Oriented-Science and Technology, Kindai University, 930 Nishimitani, Kinokawa 649-6493, Wakayama, Japan.ORCID 0000-0001-8276-3439
Kento TeradaDepartment of Obstetrics and Gynecology, Graduate School of Medicine, Mie University, 2-174 Edobashi, Tsu 514-8507, Mie, Japan.
Akira UjitsuguFaculty of Biology-Oriented-Science and Technology, Kindai University, 930 Nishimitani, Kinokawa 649-6493, Wakayama, Japan.
Yudai HiroseGraduate School of Biology-Oriented-Science and Technology, Kindai University, 930 Nishimitani, Kinokawa 649-6493, Wakayama, Japan.
Hiroki TakeuchiDepartment of Obstetrics and Gynecology, Graduate School of Medicine, Mie University, 2-174 Edobashi, Tsu 514-8507, Mie, Japan.ORCID 0000-0001-5994-7416
Masanobu KusunokiGraduate School of Biology-Oriented-Science and Technology, Kindai University, 930 Nishimitani, Kinokawa 649-6493, Wakayama, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Spheroids are expected to aid the establishment of an in vitro-based cell culture system that can realistically reproduce cellular dynamics in vivo. We developed a fluoropolymer scaffold with an extracellular matrix (ECM) dot array and confirmed the possibility of mass-producing spheroids with uniform dimensions. Controlling the quality of ECM dots is important as it ensures spheroid uniformity, but issues such as pattern deviation and ECM drying persist in the conventional microstamping method. In this study, these problems were overcome via ECM dot printing using a resin mask with dot-patterned holes. For dot diameters of φ 300 μm, 400 μm, and 600 μm, the average spheroid diameters of human iPS cells (hiPSCs) were φ 260.8 μm, 292.4 μm, and 330.7 μm, respectively. The standard deviation when each average was normalized to 100 was 14.1%. A high throughput of 89.9% for colony formation rate to the number of dots and 89.3% for spheroid collection rate was achieved. The cells proliferated on ECM dots, and the colonies could be naturally detached from the scaffold without the use of enzymes, so there was almost no stimulation of the cells. Thus, the undifferentiated nature of hiPSCs was maintained until day 4. Therefore, this method is expected to be useful in drug discovery and regenerative medicine.

Indexed as

Induced Pluripotent Stem CellsSpheroids, CellularDrug DiscoveryExtracellular MatrixHumansRegenerative MedicineiPSorganoidscaffoldspheroidundifferentiated natureuniform dimension

Identifiers

PMID36672213
PMCPMC9857117

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.